
KKR to buy Japan’s Bushu Pharmaceuticals in $749m deal
Private equity giant KKR & Co Inc has revealed plans to acquire Japanese drug developer Bushu Pharmaceuticals from BPEA EQT, a Hong Kong-based private equity firm, according to a report by Reuters.
